Naloxone Hydrochloride Injection
Product Images NDC 51662-1239

Naloxone Hydrochloride Inj., USP 2mg/2mL is a pre-filled syringe used as an Opioid Antagonist. It is used for intravenous, intramuscular or subcutaneous use, and comes in a single-use, pre-filled syringe that should not be reused or resterilized. Each mL contains Naloxone Hydrochloride, 1 mg, and Sodium Chloride, 8.35 mg, adjusted with Hydrochloric Acid. The medication and fluid pathways are sterile and nonpyrogenic in the original, unopened package. The syringe does not have a preservative and must be protected from light and stored at controlled room temperature. The usual dosage must be consulted from the insert. The NDC code for this product is 76329-3369-1, and it is manufactured by Amphastar Pharmaceuticals Company.*

This is a label of an injection packet manufactured by M Limited located in South El Monte, California, USA. The label contains details such as the brand name FORLILLY.0R, the drug name NALOXONE HYDROCHLORIDE, and the barcode number 07 003763293368. The package size mentioned is 2 mL, and the injection is of USP grade. The text also includes some alphanumeric codes such as SEz INeiT 8 and 76336908 &-11, which have an unclear meaning and context.*

This appears to be a package label or identification label on a product. It includes a product number or code of "RL088G7" and some other codes or numbers such as "00351662123911", "130630", and "43365897257". The label mentions the manufacturer's package insert, which likely contains instructions or information regarding the product. It is distributed by a company named "HF Acquisition Co.. LLC" located in Mukilteo, WA 98275.*

This is a description of Naloxone Hydrochloride Injection, USP with a concentration of 1mg/mL, contained in a syringe marked 2mg per 2 mL. There is an NDC number of 31662-1239-2 and a LOT number of 12345. The drug is used to reverse the effects of an opioid overdose and is intended for use intravenously, intramuscularly or subcutaneously. It is emphasized that the cap should only be removed when ready to use and that no preservative is included. There is also a warning about improper handling causing glass breakages. The manufacturer is HF Acquisition Co., LLC in Mukilteo, WA 98275, and there is an original manufacturing NDC number of 76329-3369-1. The storage temperature is also mentioned, with a range of 15°C to 30°C.*

Naloxone Hydrochloride Injection, USP is a medication used as an opioid antagonist for intravenous, intramuscular or subcutaneous use. It is available in a concentration of 1mg/ml and is packaged as 2mg per 2mL syringe, with a box containing 10 syringes. The drug should be stored at a controlled room temperature of 25°C (77°F) and protected from light, but short excursions between 15°-30°C (59°-86°F) are permitted. The usual dosage is specified in the insert. It is important to exercise caution while handling the drug as glass breakage may result in injury. The manufacturer is HF Acquisition Co. LLC, located in Mukilteo, WA, and the drug requires a prescription.*

This text seems to be instructions for using an injector device to inject a substance from a vial. The text provides step-by-step guidance on how to remove the protective caps from the vial, align it to the injector needle, thread the vial into the injector, and expel air before injection. It also contains a warning not to push the vial into the injector to avoid misalignment.*